Efficacy and Safety Study of Dietary Supplements in Chronic Smokers Having Mild to Moderate Hyperlipidemia
Efficacy and Safety Study of Dietary Supplements in Chronic Smokers Having Mild to Moderate Hyperlipidemia
The purpose of this study is to investigate the efficacy and safety of dietary supplements
 (BioTurmin, BioTurmin-WD and MaQxan) on cotinine level and oxidative stress marker in chronic
 smokers having mild to moderate hyperlipidemia after 30 and 60 days of intervention.
In a randomized, double-blind, placebo control trial, the efficacy and safety of dietary
 supplements (BioTurmin, BioTurmin-WD and MaQxan) will be investigated in chronic smokers
 having mild to moderate hyperlipidemia. Sixty subjects will be randomly assigned to receive
 the dietary supplements and placebo for 60 days. The efficacy of the supplements will be
 measured by estimating cotinine and malondialdehyde level.
Inclusion Criteria:

 -  Men > 20 years

 -  Chronic cigarette/ beedi smoker (2-3 packets/day since last 3 years or more) with mild
 to moderate hyperlipidemia (LDL ranging 160-189 mg/dL, TC >200 mg/dL and/or HDL-C <40
 mg/dL)

 -  Being mentally competent and able to understand all study requirements and sign the
 informed consent form.

 Exclusion Criteria:

 -  Patients with Chronic obstructive pulmonary disease (COPD)

 -  Women

 -  Patients with severe liver, renal, cardiac or brain diseases.

 -  Unable to complete follow up.

 -  Subjects on any medication like diuretics.

 -  Allergic to any medication.

 -  With a history of alcohol and/or drug abuse.